Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-28

Clinical Trial Update: An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating clavulanic acid for tobacco use disorder, with functional MRI to assess brain effects, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clavulanic Acid (clavulanic acid)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Tobacco Use Disorder | Phase 2 | Status: RECRUITING